for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Jilin Aodong Medicine Industry Group Co.

000623.SZ

Latest Trade

15.84CNY

Change

-0.30(-1.86%)

Volume

8,441,498

Today's Range

15.72

 - 

16.09

52 Week Range

13.53

 - 

19.80

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
16.14
Open
16.07
Volume
8,441,498
3M AVG Volume
126.11
Today's High
16.09
Today's Low
15.72
52 Week High
19.80
52 Week Low
13.53
Shares Out (MIL)
1,163.03
Market Cap (MIL)
18,771.33
Forward P/E
--
Dividend (Yield %)
1.24

Latest Developments

More

Jilin Aodong Pharmaceutical's H1 Net Profit Up 43.4% Y/Y

Jilin Aodong Pharmaceutical Says Q1 Net Profit Up 98.5 Percent Y/Y

Jilin Aodong Pharmaceutical Says It Sees Q1 Net Profit Up 80-105 Percent Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Jilin Aodong Medicine Industry Group Co.

Jilin Aodong Pharmaceutical Group Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines and biochemical drugs. The Company’s main products include capsules, granules, oral liquid, tablets, ointments, powder, syrup, pills, medicated wine and herbal decoction pieces, among others. The Company is also involved in the production of health food and food, as well as breeding, planting and other businesses. The Company mainly distributes its products in domestic market.

Industry

Major Drugs

Contact Info

No. 2158, Aodong Avenue, Dunhua City

+86.433.6238973

http://www.jlaod.com

Executive Leadership

Xiulin Li

Chairman of the Board

Shuqin Guo

Vice Chairman of the Board, General Manager

Shuyuan Zhang

Chief Financial Officer, Deputy General Manager

Yongfeng Chen

Secretary of the Board, Director

Yan Bi

Independent Director

Key Stats

Price To Earnings (TTM)
15.65
Price To Sales (TTM)
5.54
Price To Book (MRQ)
0.86
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
9.39
LT Debt To Equity (MRQ)
8.96
Return on Investment (TTM)
5.03
Return on Equity (TTM)
4.75

Latest News

BRIEF-Jilin Aodong Pharmaceutical Group unit receives GMP certificate

* Says Dalian-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Liaoning Food and Drug Administration

BRIEF-Jilin Aodong Pharmaceutical's H1 net profit up, to issue A-share convertible bonds

* Says H1 net profit up 8.7 percent y/y at 911.2 million yuan ($136.81 million)

BRIEF-Jilin Aodong Pharma's Q1 net profit up 15.1 pct y/y

Jilin Aodong Pharmaceutical Group Co Ltd

BRIEF-Jilin Aodong Pharma to boost two units' registered capital

* Says it plans to boost two units' registered capital for a combined 700 million yuan ($101.70 million)

BRIEF-Jilin Aodong Pharmaceutical's Q3 net profit up 23.8 pct

* Says Q3 net profit up 23.8 percent y/y at 443.4 million yuan ($65.49 million)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up